Media News

Alphamab Oncology Reports 2024 Interim Results and Business Highlights

SUZHOU, China, Aug. 16, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported interim financial results for the six months ended June 30, 2024 and highlighted recent business progress. Financial Summary For the six months ended June 30, 2024, we recorded total revenue of RMB 173.56 million, an increase of 27.18% compared with the first half of 2023....

Sanyou Bio’s Innovative Intelligent Antibody Design oneClick+ Platform is Officially Launched

SHANGHAI, Aug. 16, 2024 /PRNewswire/ -- On August 16, 2024 (local time), Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. officially announced the launch of the "Sanyou Innovative Intelligent Antibody Design oneClick+ Platform." Sanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform, independently designed by Sanyou Bio, integrates 90% of the mainstream antibody structures currently available on the market and reported in the literature....

4G Clinical Announces Appointment of Life Science Service and Tech Leader Dr. Ronan Brown as New Chief Operating Officer

Brown brings years of industry expertise to oversee and maximize 4G Clinical's operational efficiency and excellence. WELLESLEY, Mass., Aug. 16, 2024 /PRNewswire/ -- 4G Clinical, a global leader in randomization and trial supply management (RTSM) and supply forecasting optimization software for the life sciences industry, today announced the appointment of Ronan Brown,...

Vimgreen Completes Enrollment of Its Phase 2 Clinical Trial Evaluating VG081821AC for the Treatment of Parkinson’s Disease

HANGZHOU, China, Aug. 15, 2024 /PRNewswire/ -- Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling, announced today the completion of enrollment of its Phase 2 clinical trial of VG081821AC, a novel adenosine A2A receptor (A2AR) antagonist that also functions as an inverse A2AR agonist, for the treatment of early-to-mid stage Parkinson's disease. A total of...

Zepp Health Partners with Wild.AI to Offer Groundbreaking Women’s Wellness App on Amazfit Smartwatches

-Enhancing women's health with advanced wearables with hormone and cycle tracking to unlock their full potential. MILPITAS, Calif., Aug. 15, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, together with Wild.AI, a wellness app for women, today announced a groundbreaking integration of Wild.AI's advanced women's health and wellness...

Cresilon Receives FDA Clearance for TRAUMAGEL

Hemostatic gel designed to control moderate to severe bleeding in seconds and save lives NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has received U.S. Food and Drug Administration ("FDA") 510(k) clearance for TRAUMAGEL® ("TRAUMAGEL") for temporary...

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024

Gross margin increased to 79.5%; product pipeline continues to advance Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025 GAITHERSBURG, Md., Aug. 15, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and...

Fractal Launches vaidya.ai, a Multimodal Health Assistant

NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Fractal (www.fractal.ai), a global provider of artificial intelligence (AI) and advanced analytics solutions to Fortune 500® companies, announced the launch of vaidya.ai, a healthcare AI platform designed to provide free and accessible healthcare assistance to individuals. This follows Fractal's earlier launches of marshallgoldsmith.ai (coaching assistant) and kalaido.ai (a free text to image generator in...

Xinhua Silk Road: Italy-based Salov, subsidiary of China’s Bright Food Group, promotes olive oil culture through talent dev’t programs

BEIJING, Aug. 15, 2024 /PRNewswire/ -- Salov SpA (Salov), an Italy-based edible oil producer that owns the globally recognized olive oil brands Filippo Berio and Sagra and was acquired by China's Bright Food Group in 2015, has been advancing olive oil culture through talent development programs. Photo shows the olive oil products of Salov. (Provided by Salov SpA)...

AI + medical care|Neusoft Education launches the Healthcare Training Lab to support practical teaching for software-related majors in universities

HONG KONG, Aug. 15, 2024 /PRNewswire/ -- With the trend of population aging in China, the government and all sectors of society are taking active measures to address the challenges of the digital age. Following the rise of the "silver economy", the smart elderly care industry will be promising, and software will be playing a crucial role in...